Tuesday, September 11, 2012
Regulus Therapeutics Inc., of La Jolla, Calif., set terms for its initial public offering (IPO), planning to raise $50 million by offering 4.5 million shares in the price range of $10 to $12.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.